Editor-In-Chief
Dr. Satya Prakash Gupta, FNASc
OptiML Vision Inc., U.S.A.
Dr. Gupta is now a retired professor, who served various educational institutes in India, starting from a very prestigious institute such as Tata Institute of Fundamental Research (TIFR), Mumbai, and then moving to Birla Institute of Technology and Science (BITS), Pilani, where he remained for a quite long time till his retirement. Thereafter, he served Meerut Institute of Engineering and Technology (MIET), Meerut, as its Director-cum-Distinguished professor of Pharmaceutical Science, and then finally shifted to National Institute of Technical Teachers’ Training and Research (NITTTR), Bhopal, a central Government Institute, functioning under Ministry of Human Resource Development (MHRD), Government of India, from where he retired in 2015. Now he has shifted to the USA, where he is associated with an up-coming biometrics company, OptiML Vision Inc., Newark, CA.
ORCID 0000-0003-1063-443X
More
Associate Editor
Dr. Dimitra Hadjipavlou-Litina
Aristotle University of Thessaloniki, Greece
Dr. Hadjipavlou-Litina received her Ph.D. in Pharmacy at the Aristotle University of Thessaloniki, Greece under the supervision of Prof. P.N. Kourounakis. She was promoted to full professor in 2009. Her research interests involve synthesis and pharmacochemical studies on anti-inflammatory and antioxidant agents, on inhibitors of enzymes implicated in the inflammation and in the coagulation process in general, as well as the correlation of inflammation with cancer, the theoretical and experimental calculation of physicochemical parameters implicated in biological response, the relationship between structure and activity (use of Computational Chemistry in Drug Design) and analysis and comparative study of Quantitative Structure/Activity Relationships (QSAR) of various categories of drugs and bioactive molecules with the aim of commercially available calculation programs. Her research has resulted in the publication of over 210 peer-reviewed articles, over 5400 citations. She is on the editorial board of 7 journals and the editor in two. She has been awarded by the American Chemical Society twice for most assessed research published papers (Hadjipavlou-Litina D, Garg R, Hansch C. Chem. Rev. 2004, 104(9): 3751-94; Michaelidou AS, Hadjipavlou-Litina D. Chem. Rev. 2005,105(9): 3235-71).
ORCID ID 0000-0002-1844-350X
Dr. Rita Kakkar, FRSC
Delhi University, India
Dr. Kakkar, FRSC, joined the Department of Chemistry in 1984 after a three-year stint at Miranda House. She took her B.Sc. (Hons.), M.Sc., M.Phil. and Ph.D. degrees all from the University of Delhi. Her field of specialization is Physical Chemistry. She has published over 130 research papers in International journals of repute and several chapters for reputed publishers. Her research interests include the application of computational methods to the investigation of mechanistic pathways of reactions at nanosurfaces and on understanding enzyme catalysis and small molecule chemistry. She heads a large research group and has supervised forty doctoral and several M.Phil. theses. She regularly reviews papers for journals and books published by several renowned publishing houses. She has delivered invited lectures at various international conferences and is an International Advisory Board member of various international conferences on Applications of Computational Chemistry. She is strongly motivated to curriculum improvement and has conducted several workshops. She is a member of the Advisory Boards of several Indian and foreign universities and has been instrumental in introducing modern topics in the syllabi of these universities, as well as in the CBCS syllabus of UGC. She has authored a book on Atomic & Molecular Spectroscopy, published by Cambridge University Press, UK.
ORCID ID 0000-0002-8666-2288
Dr. Sunil K. Malonia
University of Massachusetts Medical School, USA
Dr. Malonia is an instructor at the University of Massachusetts Medical School, USA. He has a broad research background and 10+ years of experience in cancer molecular biology, genomics, and epigenetics. His research focuses on understanding the cellular, biochemical, and molecular basis of human diseases– particularly cancer and rare genetic disorders. The major theme of his research is to decipher various genetic and epigenetic events that contribute to the development/ or progression of these diseases and identifying regulatory pathways and druggable targets. His research interest includes Functional Genomics; Genome editing; Gene Expression and Regulation; RNA Processing and Non-coding RNAs; Gene Targeting; Gene therapy; Drug delivery; Genetic Disorders; Next-generation sequencing.
ORCID ID 0000-0002-2727-5165
Editorial Board Member
Dr. Dolly A. Parasrampuria
Janssen Research and Development, USA
Dr. Parasrampuria earned her Ph.D. from the University of California, San Francisco (UCSF), under the advisement of Dr. Leslie Z. Benet. She has a bachelor’s degree in Pharmacy (Hons) and an M.Phil from the Birla Institute of Technology & Science (BITS-Pilani). Dolly’s career of almost 20 years (~ 14 yrs at Johnson and Johnson) spans the entire range of clinical drug development from FIH through Phase 3 and post-marketing, across numerous therapeutic areas for both small and large molecules. Most recently, she was the Clinical Pharmacology Director for daratumumab (Darzalex) subcutaneous BLA. Dolly has participated in numerous due diligence evaluations of compounds and technologies. Currently, she is the Director for Licensing Evaluation at Janssen Research & Development, Spring House, Pennsylvania. She has about 70 publications that include research articles, reviews, commentary, book chapters, and filed 2 patents.
ORCID ID 0000-0003-3072-1784
Dr. Shubham Dutta
Massachusetts Biological Laboratory (MassBiologics of UMMS), USA
Dr. Dutta is a Scientist II at Massachusetts Biological Laboratory (MassBiologics of UMMS). He earned his Ph.D. in Biomedical Sciences degree in 2018 from the University of Massachusetts Medical School and then worked as a Senior Scientist in a Cambridge based biotechnology company. He has a broad research background and 8+ years of experience in Oncology, Molecular biology, Gene editing, CRISPR, Biochemistry, and Immunology. His current research focuses on understanding the cellular, biochemical, and molecular basis of cancer and certain rare genetic disorders and how genetic and epigenetic programming contribute to the progression of these diseases. He has undertaken a variety of functional genomics approaches such as RNA interference (RNAi) and CRISPR based screens, proteomics and biochemistry-based methods to identify new genes, proteins, and regulatory pathways that are the cause of or contribute to the disease state. Another area of his research is to design novel antibodies that can be in vaccination against SARS, Zika, coronavirus, and developing non-human primate models for these diseases.
ORCID ID 0000-0001-8484-0717
Dr. Ottavia Spiga
University of Siena, Italy
Dr. Spiga, Researcher at Biotechnology Chemistry and Pharmacology Department, obtained her Bachelor’s degree in Biology and received her Ph.D. degree in Biotechnology from the University of Siena in 2002. Dr. Spiga has published her work in many renowned journals in the field of Structural and Molecular Biology and Computational Biology. Her strong interest in molecular modeling and computational docking analysis led her to participate in many research projects globally. Research of interest: NMR structure determination of biological macromolecules, protein surface accessibility investigated with paramagnetic probes and hydration NMR techniques, and computer-aided molecular modeling and docking.
ORCID ID 0000-0002-0263-7107
Dr. Swati S. More
University of Minnesota, USA
Dr. More received her Ph.D. in Medicinal Chemistry from the University of Minnesota and acquired postdoctoral training in pharmacokinetics and pharmacogenomics at the University of California, San Francisco. Dr. More was appointed to the faculty of the Center for Drug Design, College of Pharmacy at the University of Minnesota in 2013. Research in her laboratory seeks to identify, describe, and solve biological problems through chemical means. A keen emphasis is placed on mechanistic probes into neurodegeneration, with diagnostic tools and therapeutic agents being the end-goals. A broad range of techniques is employed toward these ends, ranging from animal behavior studies, molecular biology, organic synthesis, rational drug design, biophysics, imaging, and microscopy. Dr. More in collaboration with Prof. Robert Vince at the Center for Drug Design has developed a retinal hyperspectral imaging technique that has shown promise as an early diagnostic tool for Alzheimer’s disease. This technology has recently been licensed to RetiSpec, a medical device company focused on Alzheimer’s detection, with the hope that it will be developed into a product approved for use by the public.
ORCID ID 0000-0002-8733-2029
Dr. Driss Cherqaoui
University of Cadi Ayyad, Morocco
Dr. Cherqaoui received his Ph.D. in Chemoinformatics at the University of Caen, Normandy (France) under the supervision of Prof. Didier Villemin. He was promoted to full professor in 2001. He has excellent research publications and some reviews to his credit, about molecular modeling and drug design, in esteemed journals. He is a reviewer for many scientific conferences, journals, and organizations.
ORCID ID 0000-0003-1327-306X
Dr. Mihail Lucian Birsa
Alexandru Ioan Cuza University of Iasi, Romania
Dr. Birsa is currently a Professor in the Department of Chemistry at the Alexandru Ioan Cuza University of Iasi, Romania. He received a Bachelor of Science degree in Chemistry from the same university in 1995. He joined the master’s program at the Alexandru Ioan Cuza University of Iasi in 1995, and in 2000 was awarded a Ph. D. degree in Organic Chemistry. From 2000 to 2002, he was a postdoctoral fellow under the mentorship of Professor Samuel Braverman at Bar-Ilan University, Israel. In 2003 he was selected as a member of the Alexander von Humboldt Foundation, working with Professor Henning Hopf in TU Braunschweig – Germany. Since then numerous return fellowships were granted by the Alexander von Humboldt Foundation.
ORCID ID 0000-0003-4483-873X
Dr. Laura Gabriela Sarbu
Alexandru Ioan Cuza University of Iasi, Romania
Dr. Sarbu is currently an Associate Professor in the Department of Chemistry at the Alexandru Ioan Cuza University of Iasi, Romania. She received a Bachelor of Science degree in Chemistry from the same university in 2007. She joined the master’s program at the Alexandru Ioan Cuza University of Iasi in 2007, and in 2015 she was awarded a Ph.D. degree in Organic Chemistry. During the Ph.D. program, she joined several times, Prof. Henning Hopf research team in TU Braunschweig – Germany. Her research interest comprises Organic Synthesis, Synthetic Drugs, Cyclophanes, Flavonoids, Sulfur Compounds.
ORCID ID 0000-0003-1789-2108
Dr. Medhat A. A. Ibrahim
National Research Centre, Egypt
Dr. Ibrahim graduated from the Physics Department, Helwan University in 1990. Joined Spectroscopy Department in 1992 as Research Assistant. He obtained Ph.D. in Experimental Physics from Cairo University in 2000, then was appointed as a Researcher in the Spectroscopy Department, NRC. He was Guest Scientist at Juelich Research Center, Germany in 2001/2002; TU-Berlin, Germany in 2007; Chinese Academy of Science in 2008, CNR Rome, Italy in 2013, 2014, 2015, 2016, 2017, 2018 and 2020 Erciyes University, Turkey in 2013 and 2014, and JINR, Russia in 2015 2016, 2018 and 2019. He is currently a Professor of Applied Spectroscopy and former head of the Spectroscopy Department from 2011 to 2017. Head of Physics Division, NRC since 05-2020. He was the Secretary of the Committee of Safety and Occupational Health (2005-2006) at NRC. He was a member of the National Committee of Physics from 2013 to 2018; then once more from 2018. He is an associate editor in Review in Theoretical Science; member of the editorial advisory board in Mini-Reviews in Medicinal Chemistry; and Journal of Applied Solution Chemistry and Modeling. He supervised 29 theses and worked as a member and PI in 27 research projects. His total citations in Scopus equal 2859 and his h-index is 27. He published 259 papers and received 19 prizes and awards, the State Award of Excellence in Advanced Technology Sciences, ASRT 2019; Golden Medal in the 6th Cairo International Exhibition for Innovation, ASRT, 24-25 October 2019; State Award in Science and Arts, First Grade, February 2020.
ORCID ID 0000-0002-9698-0837
Dr. Yenamandra S. Prabhakar
Central Drug Research Institute (CDRI), India
Dr. Prabhakar has retired as a Chief Scientist and Professor AcSIR, Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow, India. Dr. Prabhakar started his research career in 1981 from BITS Pilani, India and furthered his research in various Institutes across the country. His research work covers various aspects of theoretical drug design and molecular modelling, physicochemical aspects of organic compounds, theoretical organic chemistry, computational biology, informatics and development of software for chemistry and drug research. He has published more than ninety peer reviewed research articles, including reviews and book chapters, in SCI journals. Some of his salient contributions include feature selection approach CP-MLR, critical exploration of artificial neural networks, algorithm for unique representation of chemical structures, and de novo approach for drug target identification. Dr. Prabhakar was a recipient of senior DAAD fellowship and worked as Visiting Scientist, Department of Pharmaceutical Chemistry, Martin-Luther University, Halle, Germany. He has mentored many post-graduate students in their research projects. Four candidates have completed their doctoral thesis under his supervision and one candidate is working for his doctoral thesis.
ORCID ID 0000-0002-9156-2441
Dr. Vaishali M. Patil
K.I.E.T. School of Pharmacy, India
Dr. Patil has completed her Ph.D. from Birla Institute of Technology, Mesra, India and has academic and industry experience of 15 years. Dr. Patil is an Associate Professor (Pharmaceutical Chemistry) at K.I.E.T. Group of Institutions, Ghaziabad, India. Her research interests are synthetic chemistry, computational chemistry, QSAR, and their application for the development of biologically active agents. Dr. Vaishali has excellent research publications and some reviews to her credit in esteemed journals and few chapters in Elsevier, Nova, and Springer Birkhauser Verlag, Basel published books.
ORCID ID 0000-0002-5352-7872
Dr. Mohd Asif Siddiqui
Meerut Institute of Engineering and Technology, India
Dr. Siddiqui is currently employed as Assistant Professor and Head, Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut, UP, India. He heads Bioinformatics laboratory. He earned his Ph.D. from Kumaun University, Nainital and did his masters from CCS University, Meerut. He has published over 20 research articles in reputed journals and 1 book. Dr. Siddiqui’s research contributions are highly interdisciplinary, spanning a wide range in biotechnology, microbiology and bioinformatics.
ORCID ID 0000-0003-4667-0029
